Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
mPactAir was a U.S. mask and protective-equipment company that marketed the mPactAir99 reusable nanofiber face mask. Publicly available information indicates the company operated as mPactAir, LLC and announced in April 2021 that BMT Fibers had appointed it as a strategic production partner for launch of the mPactAir99 mask. The product was positioned as a high-filtration, washable, reusable non-medical mask using BMT NanoScreen technology and manufactured in the United States. Based on the available evidence, mPactAir appears to have been a small commercial-stage protective-device company rather than a drug-development biotech or pharmaceutical company. Current evidence for ongoing operations is limited, so the company appears inactive or dormant.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on mPactAir.